Search research articles
Contact Us
Filters
Showing results (71-80 of 161) with videos related to
Page
of 17
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 27, 2018
Effect of hepatitis B virus (HBV) surface-gene variability on markers of replication during treated human immunodeficiency virus-HBV infection in Western Africa
Anders Boyd, Raoul Moh, Sarah Maylin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
June 12, 2008
HIV-1 DNA in peripheral blood mononuclear cells is strongly associated with HIV-1 disease progression in recently infected West African adults
Albert K Minga, Xavier Anglaret, Thomas d' Aquin Toni, et al.
World Journal of Hepatology
|
August 3, 2012
Prevalence and virological profiles of hepatitis B infection in human immunodeficiency virus patients
Koffi Alain Attia, Serge Eholié, Eugène Messou, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
October 27, 2011
CD4-specific mortality rates among HIV-infected adults with high CD4 counts and no antiretroviral treatment in West Africa
Charlotte Lewden, Delphine Gabillard, Albert Minga, et al.
AIDS (London, England)
|
July 30, 2005
Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysis
Yazdan Yazdanpanah, Elena Losina, Xavier Anglaret, et al.
Plos One
|
June 30, 2010
The financial burden of morbidity in HIV-infected adults on antiretroviral therapy in Côte d'Ivoire
Arnousse Beaulière, Siaka Touré, Pierre-Kébreau Alexandre, et al.
Plos Neglected Tropical Diseases
|
March 25, 2016
A 6-Year-Old Child with Severe Ebola Virus Disease: Laboratory-Guided Clinical Care in an Ebola Treatment Center in Guinea
Romain Palich, Jean-Luc Gala, Frédéric Petitjean, et al.
American Journal of Epidemiology
|
October 26, 2016
What Level of Risk Compensation Would Offset the Preventive Effect of Early Antiretroviral Therapy? Simulations From the TEMPRANO Trial
Kévin Jean, Marie-Claude Boily, Christine Danel, et al.
The Journal of Infectious Diseases
|
November 7, 2008
Two-months-off, four-months-on antiretroviral regimen increases the risk of resistance, compared with continuous therapy: a randomized trial involving West African adults
Christine Danel, Raoul Moh, Marie-Laure Chaix, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
April 21, 2010
Laboratory monitoring to guide switching antiretroviral therapy in resource-limited settings: clinical benefits and cost-effectiveness
April D Kimmel, Milton C Weinstein, Xavier Anglaret, et al.
Page
of 17
Search research articles
Search
Showing results (71-80 of 161) with videos related to
Sort By:
Page
of 17
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 27, 2018
Effect of hepatitis B virus (HBV) surface-gene variability on markers of replication during treated human immunodeficiency virus-HBV infection in Western Africa
Anders Boyd, Raoul Moh, Sarah Maylin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
June 12, 2008
HIV-1 DNA in peripheral blood mononuclear cells is strongly associated with HIV-1 disease progression in recently infected West African adults
Albert K Minga, Xavier Anglaret, Thomas d' Aquin Toni, et al.
World Journal of Hepatology
|
August 3, 2012
Prevalence and virological profiles of hepatitis B infection in human immunodeficiency virus patients
Koffi Alain Attia, Serge Eholié, Eugène Messou, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
October 27, 2011
CD4-specific mortality rates among HIV-infected adults with high CD4 counts and no antiretroviral treatment in West Africa
Charlotte Lewden, Delphine Gabillard, Albert Minga, et al.
AIDS (London, England)
|
July 30, 2005
Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysis
Yazdan Yazdanpanah, Elena Losina, Xavier Anglaret, et al.
Plos One
|
June 30, 2010
The financial burden of morbidity in HIV-infected adults on antiretroviral therapy in Côte d'Ivoire
Arnousse Beaulière, Siaka Touré, Pierre-Kébreau Alexandre, et al.
Plos Neglected Tropical Diseases
|
March 25, 2016
A 6-Year-Old Child with Severe Ebola Virus Disease: Laboratory-Guided Clinical Care in an Ebola Treatment Center in Guinea
Romain Palich, Jean-Luc Gala, Frédéric Petitjean, et al.
American Journal of Epidemiology
|
October 26, 2016
What Level of Risk Compensation Would Offset the Preventive Effect of Early Antiretroviral Therapy? Simulations From the TEMPRANO Trial
Kévin Jean, Marie-Claude Boily, Christine Danel, et al.
The Journal of Infectious Diseases
|
November 7, 2008
Two-months-off, four-months-on antiretroviral regimen increases the risk of resistance, compared with continuous therapy: a randomized trial involving West African adults
Christine Danel, Raoul Moh, Marie-Laure Chaix, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
April 21, 2010
Laboratory monitoring to guide switching antiretroviral therapy in resource-limited settings: clinical benefits and cost-effectiveness
April D Kimmel, Milton C Weinstein, Xavier Anglaret, et al.
Page
of 17